Enricture is a rapid, cost effective, and low risk screening platform efficient ligand discovery. By combining Affinity Selection–Mass Spectrometry (ASMS) with proprietary AI/ML-driven hit enrichment, it accelerates your drug discovery journey without compromising quality.
Explore how Enricture can transform your drug discovery:
The unique benefits of the Enricture for ligandability assessment and Hit IDA breakdown of the highly efficient 3-stage Enricture workflowAn overview of ASMS technology and its key advantagesHow Evotec integrates existing bioactivity screening data, on-target ASMS results and structural information using proprietary AI/ML algorithms to advance hit enrichment